Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres
Authors
Keywords
-
Journal
Communications Biology
Volume 5, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-10
DOI
10.1038/s42003-022-03402-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Glioma Stem Cell Model in the Era of Single-Cell Genomics
- (2020) Mario L. Suvà et al. CANCER CELL
- Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes
- (2020) Ekaterina Friebel et al. CELL
- HSP70/IL-2 Treated NK Cells Effectively Cross the Blood Brain Barrier and Target Tumor Cells in a Rat Model of Induced Glioblastoma Multiforme (GBM)
- (2020) Farzaneh Sharifzad et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironment
- (2020) Darwin Kwok et al. JOURNAL OF NEURO-ONCOLOGY
- CCR5-Mediated Signaling is Involved in Invasion of Glioblastoma Cells in Its Microenvironment
- (2020) Metka Novak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Considering the Experimental Use of Temozolomide in Glioblastoma Research
- (2020) Verena J. Herbener et al. Biomedicines
- Exploring the NK cell platform for cancer immunotherapy
- (2020) Jacob A. Myers et al. Nature Reviews Clinical Oncology
- Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells
- (2020) Kawaljit Kaur et al. Scientific Reports
- Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma
- (2019) Tanwir Hasan et al. Cell Death & Disease
- Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment
- (2019) Anne Dirkse et al. Nature Communications
- Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer
- (2019) Ryan C. Gimple et al. GENES & DEVELOPMENT
- Similarities Between Stem Cell Niches in Glioblastoma and Bone Marrow: Rays of Hope for Novel Treatment Strategies
- (2019) Vashendriya V.V. Hira et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Microenvironmental Heterogeneity in Brain Malignancies
- (2019) Lucas J. M. Perus et al. Frontiers in Immunology
- MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/β-catenin signaling pathway
- (2019) Wei Yang et al. ONCOGENE
- Brain malignancies: Glioblastoma and brain metastases
- (2019) Tamara T. Lah et al. SEMINARS IN CANCER BIOLOGY
- CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
- (2019) Michael C. Burger et al. Frontiers in Immunology
- Natural killer cells; diverse functions in tumor immunity and defects in pre-neoplastic and neoplastic stages of tumorigenesis
- (2019) Anahid Jewett et al. Molecular Therapy-Oncolytics
- A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity
- (2019) Fadi Jacob et al. CELL
- Probiotic-Treated Super-Charged NK Cells Efficiently Clear Poorly Differentiated Pancreatic Tumors in Hu-BLT Mice
- (2019) Kawaljit Kaur et al. Cancers
- The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma
- (2018) Diana A. Aderetti et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
- (2018) Kevin C. Barry et al. NATURE MEDICINE
- Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α
- (2018) Qirui Wang et al. Nature Communications
- Glioblastoma Stem-Like Cells Are More Susceptible Than Differentiated Cells to Natural Killer Cell Lysis Mediated Through Killer Immunoglobulin-Like Receptors–Human Leukocyte Antigen Ligand Mismatch and Activation Receptor–Ligand Interactions
- (2018) Heleen Neeltje Haspels et al. Frontiers in Immunology
- Super-charged NK cells inhibit growth and progression of stem-like/poorly differentiated oral tumors in vivo in humanized BLT mice; effect on tumor differentiation and response to chemotherapeutic drugs
- (2018) Kawaljit Kaur et al. OncoImmunology
- NK Cell-Based Glioblastoma Immunotherapy
- (2018) Irene Golán et al. Cancers
- Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma
- (2017) Wilson X Mai et al. NATURE MEDICINE
- Mesenchymal stem cells differentially affect the invasion of distinct glioblastoma cell lines
- (2017) Barbara Breznik et al. Oncotarget
- Novel Strategy to Expand Super-Charged NK Cells with Significant Potential to Lyse and Differentiate Cancer Stem Cells: Differences in NK Expansion and Function between Healthy and Cancer Patients
- (2017) Kawaljit Kaur et al. Frontiers in Immunology
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells
- (2016) Anna K. Kozlowska et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells
- (2016) Yu Shi et al. CELL DEATH AND DIFFERENTIATION
- Targeting natural killer cells in cancer immunotherapy
- (2016) Camille Guillerey et al. NATURE IMMUNOLOGY
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells
- (2015) Neža Podergajs et al. Oncotarget
- Differential Targeting of Stem Cells and Differentiated Glioblastomas by NK Cells
- (2015) Han-Ching Tseng et al. Journal of Cancer
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- Effect of tumor cells and tumor microenvironment on NK-cell function
- (2014) Massimo Vitale et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level
- (2013) Justyna Kmiecik et al. JOURNAL OF NEUROIMMUNOLOGY
- Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA
- (2013) David A. Nathanson et al. SCIENCE
- Human Glioblastoma Stem-Like Cells are More Sensitive to Allogeneic NK and T Cell-Mediated Killing Compared with Serum-Cultured Glioblastoma Cells
- (2011) Tony Avril et al. BRAIN PATHOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now